Leritrelvir (RAY1216) 是一种具有口服活性的 SARS-CoV-2 主要蛋白酶慢紧抑制剂，Ki 为 8.6 nM。

Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration.

丹酚酸D和三七三萜能够促进EA-hy926及其蛋白的表达，对EA-hy926细胞的体外血管生成具有保护作用。